News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|December 1, 2007

Guide for Practitioners: Annular erythema in children

Annular erythema in children

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

Q&A: Keisha Gibson, MD, discusses the FDA priority review of obinutuzumab for pediatric INS

ByKeisha L. Gibson, MD, MPH

July 14th 2026

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

Trisha Torga, MD, on how social media skincare trends may be driving skin irritation in adolescents

ByTrisha Torga, MD

July 14th 2026

Nonreceipt of newborn intramuscular vitamin K linked to doubled bleeding risk | Image Credit: © Pixel_Studio_8 - Adobe Stock

Nonreceipt of newborn intramuscular vitamin K linked to doubled bleeding risk

ByMorgan Ebert, Executive Editor

July 14th 2026

FDA accepts sNDA for vosoritide in children with achondroplasia

FDA accepts sNDA for vosoritide in children with achondroplasia

ByMorgan Ebert, Executive Editor

July 13th 2026

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

ByMorgan Ebert, Executive Editor

July 13th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA presses infant formula makers to tighten supplier oversight after botulism and cereulide events

ACIP dropped MMRV coverage. New data show it was a lifeline for VFC-eligible kids

FDA accepts sNDA for vosoritide in children with achondroplasia

RSV Immunization Rates and Vaccine Hesitancy: Practical Strategies for Clinicians

RSV and the Challenge of Reinfection: Long-Term Prevention Perspectives